Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00883740 · ClinicalTrials.gov registry record · Phase 3

Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia

A Phase 3 study of Fibromyalgia and Sleep Disorders, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.

Completed
Registry status
Phase 3
Development phase
119
Enrollment target
20
Study locations

NCT00883740 is a Phase 3 study of Fibromyalgia and Sleep Disorders that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 119 participants, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (33% lower). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00883740, a Phase 3 study of Fibromyalgia and Sleep Disorders, has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.

COMPLETED
Registry status
Phase 3
Development phase
119 participants
Enrollment target
20
Study locations

Study Summary

The purpose of the study is to demonstrate the effect of Lyrica on Wake after sleep onset in subjects with fibromyalgia with sleep maintenance disturbance (on polysomnogram)

Conditions Studied

Fibromyalgia Sleep Disorders

Interventions

  • DRUG Placebo
  • DRUG Pregabalin

Study Locations (20)

Florida

  • Pfizer Investigational Site - DeLand
  • Pfizer Investigational Site - Hallandale
  • Pfizer Investigational Site - Orange City
  • Pfizer Investigational Site - Pembroke Pines
  • Pfizer Investigational Site - South Miami

Arizona

  • Pfizer Investigational Site - Phoenix
  • Pfizer Investigational Site - Phoenix
  • Pfizer Investigational Site - Tucson

Kentucky

  • Pfizer Investigational Site - Crestview Hills
  • Pfizer Investigational Site - Louisville

Mississippi

  • Pfizer Investigational Site - Hattiesburg
  • Pfizer Investigational Site - Hattiesburg

California

  • Pfizer Investigational Site - San Diego

Colorado

  • Pfizer Investigational Site - Colorado Springs

Georgia

  • Pfizer Investigational Site - Atlanta

Illinois

  • Pfizer Investigational Site - Chicago

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2009-06
Est. Completion 2010-06
Phase Phase 3

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris

158 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00883740

The ClinicalTrials.gov registry entry for NCT00883740 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (33% lower). The listed sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Fibromyalgia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00883740 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Florida, Arizona, Kentucky.

Frequently Asked Questions

What is clinical trial NCT00883740 about?

NCT00883740 is a clinical study titled "Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia". The purpose of the study is to demonstrate the effect of Lyrica on Wake after sleep onset in subjects with fibromyalgia with sleep maintenance disturbance (on polysomnogram)

What is the current status of trial NCT00883740?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 119 participants. The study started on 2009-06. Estimated completion is 2010-06.

What conditions does trial NCT00883740 study?

This clinical trial studies the following conditions: Fibromyalgia, Sleep Disorders.

What interventions are being tested in trial NCT00883740?

The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG).

Who is sponsoring clinical trial NCT00883740?

This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00883740 being conducted?

This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fibromyalgia

All registered trials for this condition

Sleep Disorders

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.